1. Anti-infection Metabolic Enzyme/Protease
  2. HIV HIV Integrase
  3. GSK3739936

GSK3739936  (Synonyms: BMS-986180)

目录号: HY-150080
产品使用指南

GSK3739936 (BMS-986180) 是一种有效的 HIV-1 变构整合酶 (HIV-1 allosteric integrase) 抑制剂,IC50 为 11.1 nM,EC50 为 1.7 nM。GSK3739936 也是一种弱 CYP 抑制剂 (IC50>24.3 μM)。GSK3739936 在实验动物中表现出良好的药代动力学特性,吸收快、清除率低至中等,以及口服生物利用度良好。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

GSK3739936 Chemical Structure

GSK3739936 Chemical Structure

CAS No. : 1803444-21-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

GSK3739936 (BMS-986180) is a potent HIV-1 allosteric integrase inhibitor with an IC50 value of 11.1 nM and an EC50 value of 1.7 nM. GSK3739936 is also a weak CYP inhibitor (IC50>24.3 μM). GSK3739936 shows favorable pharmacokinetic property in preclinical species with rapid absorption, low to moderate clearance and excellent oral bioavailability[1].

IC50 & Target

IC50: 11.1 nM (HIV-1 integrase)[1]
EC50: 1.7 nM (HIV-1 integrase)[1]
IC50: >24.3 μM (CYP)[1]

体外研究
(In Vitro)

GSK3739936 is not cytotoxic to MT-2 cells, exhibiting CC50 values of >20 μM[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

GSK3739936 exhibits favorable pharmacokinetic property with rapid absorption, low to moderate clearance and excellent oral bioavailability[1].
Pharmacokinetic Parameters of GSK3739936 in Preclinical Species[1].

Male CD-1 mice Male Sprague-Dawley rats Cynomolgus monkey Male beagle dogs
IV dose (mg/kg) 1 1 1 1
CL (mL/min/kg) 5.4 5.5 14.5 2.9
t1/2 (h) 6.3 4.3 2.4 5.1
Vss (L/kg) 2.4 1.8 1.5 0.7
PO dose (mg/kg) 5 5 2 2
Cmax (nM) 2361 2762 525 2963
tmax (h) 5 2.7 2 2
AUC (nM·h) 24516 14022 2231 18471
F (%) 89 52 54 75

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male CD-1 mice, male Sprague-Dawley rats, cynomolgus monkey and male beagle dogs[1]
Dosage: 1 mg/kg for IV; 5 or 2 mg/kg for PO
Administration: PO or IV; single dosage
Result: Exhibited a low clearance in the mouse, rat, and dog with moderate to long elimination half-lives, while displays moderate clearance and a short elimination half-life in the cynomolgus monkey.
The absolute oral bioavailability ranged between 52 and 89%.
The tmax value of 2-5 h suggesting rapid absorption in all four species.
分子量

562.71

Formula

C34H43FN2O4

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
GSK3739936
目录号:
HY-150080
需求量: